Analytical Data
-
Gene name
pla
- Application
-
Alternative Names
Plasminogen activator
-
Species
Yersinia pestis
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P17811
-
Expression Region
21-312aa
-
Molecular Weight
40.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The research on recombinant proteins, particularly those derived from poly-lactic acid (PLA), has gained significant attention in recent years due to their potential applications in various fields, including biomedical engineering, pharmaceutical development, and materials science. PLA is a biodegradable and biocompatible polymer derived from renewable resources, making it an attractive alternative to traditional petroleum-based plastics. The ability to produce recombinant proteins that incorporate PLA has opened new avenues for designing advanced drug delivery systems, tissue engineering scaffolds, and bioactive materials. These proteins can be engineered to exhibit specific properties, such as enhanced stability, controlled release rates, and targeted delivery mechanisms, which are critical for improving the efficacy of therapeutics. Moreover, the integration of PLA in recombinant protein design not only enhances their mechanical properties but also promotes environmental sustainability, addressing the growing concerns over plastic waste and pollution. As researchers continue to explore the intersection of bioengineering and polymer science, the development of PLA-based recombinant proteins promises to lead to innovative solutions in healthcare and beyond, paving the way for the next generation of sustainable biomaterials.
